Industry Developments
China
BMI View: Major domestic pharmaceutical companies will benefit from China's 12th five-year plan (FYP) for the pharmaceutical industry, as the government aims to improve the whole industry...
2012-02-07Japan
BMI View: Astellas performed well in fiscal 9M11, with net income increasing by nearly a third. We believe the company could expand its business in the emerging markets to build upon...
2012-02-03Japan
BMI View: Japan's medical device market is an attractive proposition to local and foreign companies. Sales have grown consistently over the past decade and we forecast sustained expansion...
2012-01-23South Korea
BMI View: BMI's view on the liberalisation of South Korea's over-the-counter (OTC) sector is playing out as the government will allow the sale of OTC drugs in convenience stores. We...
2012-01-03Sri Lanka
BMI View: While it is clear that the implementation of a medicine pricing policy will work towards controlling public pharmaceuticals and healthcare expenditure, we believe that it...
2011-12-14South Korea
BMI Core View: Non-healthcare companies, particularly technology firms, will increasingly enter the medical services sector. Companies see healthcare as a sustainable and expanding...
2011-12-07China
BMI View: China's huge population of drug-naïve patients, coupled with the increasingly ageing population (and hence increasing burden from non-communicable diseases), will generate...
2011-12-06India
BMI View: Clinical research organisations (CROs) will increasingly penetrate India's clinical trial sector. Robust economic expansion and relative political stability will support development...
2011-12-02
